Healthcare provider profile · identity verified

Satish Chandra, M.D.

Internal Medicine · SANTA CRUZ, CA · NPI 1659474542

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	400	111
Amlodipine Besylate	Amlodipine Besylate	383	112
Lisinopril	Lisinopril	291	89
Gabapentin	Gabapentin	257	56
Losartan Potassium	Losartan Potassium	237	64
Metformin Hcl	Metformin Hcl	219	61
Hydrochlorothiazide	Hydrochlorothiazide	218	60
Levothyroxine Sodium	Levothyroxine Sodium	186	55
Rosuvastatin Calcium	Rosuvastatin Calcium	184	61
Omeprazole	Omeprazole	180	52
Metoprolol Succinate	Metoprolol Succinate	173	53
Tamsulosin Hcl	Tamsulosin Hcl	168	40
Furosemide	Furosemide	156	43
Eliquis	Apixaban	151	41
Escitalopram Oxalate	Escitalopram Oxalate	147	41
Trazodone Hcl	Trazodone Hcl	114	29
Jardiance	Empagliflozin	86	22
Pantoprazole Sodium	Pantoprazole Sodium	84	23
Potassium Chloride	Potassium Chloride	77	21
Glipizide	Glipizide	71	19
Allopurinol	Allopurinol	67	21
Zolpidem Tartrate	Zolpidem Tartrate	66	16
Albuterol Sulfate Hfa	Albuterol Sulfate	65	19
Simvastatin	Simvastatin	62	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	15
Tramadol Hcl	Tramadol Hcl	60	18
Pravastatin Sodium	Pravastatin Sodium	59	17
Fluticasone Propionate	Fluticasone Propionate	57	20
Irbesartan	Irbesartan	56	14
Bupropion Xl	Bupropion Hcl	53	12
Sertraline Hcl	Sertraline Hcl	49	18
Alprazolam	Alprazolam	48	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	48	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Carvedilol	Carvedilol	47	14
Lorazepam	Lorazepam	47	13
Citalopram Hbr	Citalopram Hydrobromide	46	11
Xarelto	Rivaroxaban	41	suppressed
Alendronate Sodium	Alendronate Sodium	39	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Labetalol Hcl	Labetalol Hcl	39	suppressed
Ibandronate Sodium	Ibandronate Sodium	38	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	12
Mirtazapine	Mirtazapine	37	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	36	suppressed
Clonazepam	Clonazepam	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	32	suppressed
Prednisone	Prednisone	32	17
Famotidine	Famotidine	30	suppressed
Myrbetriq	Mirabegron	29	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Metronidazole	Metronidazole	28	suppressed
Colchicine	Colchicine	27	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Atenolol	Atenolol	26	suppressed
Midodrine Hcl	Midodrine Hcl	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Finasteride	Finasteride	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	11
Valacyclovir	Valacyclovir Hcl	24	13
Warfarin Sodium	Warfarin Sodium	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Ketoconazole	Ketoconazole	22	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Lovastatin	Lovastatin	21	suppressed
Azithromycin	Azithromycin	20	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	12
Valsartan	Valsartan	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Estradiol	Estradiol	18	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Flecainide Acetate	Flecainide Acetate	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Nystatin	Nystatin	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Testosterone	Testosterone	17	suppressed
Torsemide	Torsemide	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Primidone	Primidone	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Baclofen	Baclofen	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Ozempic	Semaglutide	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	13
Benazepril Hcl	Benazepril Hcl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Cyclosporine	Cyclosporine	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Indapamide	Indapamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error